Literature DB >> 12137939

Basal transcription activity of the dyskeratosis congenita gene is mediated by Sp1 and Sp3 and a patient mutation in a Sp1 binding site is associated with decreased promoter activity.

Rüdiger Salowsky1, Nina S Heiss, Axel Benner, Rainer Wittig, Annemarie Poustka.   

Abstract

The multisystem disorder dyskeratosis congenita (DKC) is caused by mutations in the DKC1 gene. The protein dyskerin is a component of the box H+ACA small nucleolar RNAs (snoRNAs) and is also functionally associated with the RNA component of the human telomerase. The majority of mutations are missense mutations, although single examples of non-coding mutations have been described. One of these is a point mutation in a putative Sp1 binding site in the 5'-upstream region of the DKC1 gene which presumably represents the promoter region of the gene. In this report, we compare the promoter sequences of both the human and mouse genes and provide a first functional characterisation of the human DKC1 promoter. This includes a characterisation of the disease-associated implications caused by the mutation identified in one patient. By reporter gene analysis, functional regions of the DKC1 promoter were delineated. The core promoter region critical for basal level of transcription was found to lie at -10 to -180. Bandshift- and supershift experiments clearly demonstrated a mutual binding of transcription factors Sp1 and Sp3 to two of five putative GC-box/Sp1-binding sites located within the core promoter region. An additional GC-box interacts only with the Sp1 transcription factor. Further, we provide evidence that the DKC1 mutation in one of the Sp1 binding sites results in reduced promoter activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12137939     DOI: 10.1016/s0378-1119(02)00725-4

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  11 in total

1.  Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy.

Authors:  T C Hart; M C Gorry; P S Hart; A S Woodard; Z Shihabi; J Sandhu; B Shirts; L Xu; H Zhu; M M Barmada; A J Bleyer
Journal:  J Med Genet       Date:  2002-12       Impact factor: 6.318

2.  Telomere dynamics in induced pluripotent stem cells: Potentials for human disease modeling.

Authors:  Hinh Ly
Journal:  World J Stem Cells       Date:  2011-10-26       Impact factor: 5.326

Review 3.  The many facets of H/ACA ribonucleoproteins.

Authors:  U Thomas Meier
Journal:  Chromosoma       Date:  2005-03-16       Impact factor: 4.316

4.  Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity.

Authors:  Michael Y Zhang; Siobán B Keel; Tom Walsh; Ming K Lee; Suleyman Gulsuner; Amanda C Watts; Colin C Pritchard; Stephen J Salipante; Michael R Jeng; Inga Hofmann; David A Williams; Mark D Fleming; Janis L Abkowitz; Mary-Claire King; Akiko Shimamura
Journal:  Haematologica       Date:  2014-09-19       Impact factor: 9.941

5.  H/ACA small RNA dysfunctions in disease reveal key roles for noncoding RNA modifications in hematopoietic stem cell differentiation.

Authors:  Cristian Bellodi; Mary McMahon; Adrian Contreras; Dayle Juliano; Noam Kopmar; Tomoka Nakamura; David Maltby; Alma Burlingame; Sharon A Savage; Akiko Shimamura; Davide Ruggero
Journal:  Cell Rep       Date:  2013-05-23       Impact factor: 9.423

6.  Telomere dysfunction in human diseases: the long and short of it!

Authors:  Kathryn A Carroll; Hinh Ly
Journal:  Int J Clin Exp Pathol       Date:  2009-05-10

7.  Insight into the Protein Components of the Box H/ACA RNP.

Authors:  John Karijolich; Yi-Tao Yu
Journal:  Curr Proteomics       Date:  2008-07-01       Impact factor: 0.837

8.  Pathogenic NAP57 mutations decrease ribonucleoprotein assembly in dyskeratosis congenita.

Authors:  Petar N Grozdanov; Narcis Fernandez-Fuentes; Andras Fiser; U Thomas Meier
Journal:  Hum Mol Genet       Date:  2009-09-04       Impact factor: 6.150

9.  Telomerase dysfunction and dyskeratosis congenita.

Authors:  Amanda J Walne; Inderjeet Dokal
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

10.  A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal Haemoglobinuria.

Authors:  W Nicol Keith; Tom Vulliamy; Jiangqin Zhao; Cem Ar; Can Erzik; Alan Bilsland; Birsen Ulku; Anna Marrone; Philip J Mason; Monica Bessler; Nedime Serakinci; Inderjeet Dokal
Journal:  BMC Blood Disord       Date:  2004-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.